ROCR Value Based Program Act
ROCR Value Based Program Act
Plain Language Summary
# ROCR Value Based Program Act - Plain Language Summary **What the Bill Does:** This bill would create a new Medicare payment system specifically for radiation therapy (a cancer treatment that uses radiation beams). Instead of paying for individual radiation therapy sessions, Medicare would pay healthcare providers a single bundled payment for an entire episode of cancer treatment. The payment would cover the planning and delivery of radiation therapy over a set timeframe: 30 days for patients with cancer that has spread to bones or the brain, or 90 days for other cancer types. **Who It Affects:** The bill would affect radiation oncology providers and suppliers who treat Medicare patients, including hospital outpatient departments, physician group practices, and freestanding radiation therapy centers. Participation would be mandatory for most Medicare-participating facilities, unless they're part of certain state-based programs.
Ultimately, Medicare patients receiving radiation therapy would be affected by how this new payment system changes the care they receive. **Key Provision & Current Status:** The main provision establishes this new "value-based" payment model, meaning providers are paid for overall treatment outcomes rather than individual services. This aims to encourage efficiency and potentially improve care quality. The bill is currently in committee and has not yet been voted on by either chamber of Congress.
CRS Official Summary
Radiation Oncology Case Rate Value Based Program Act of 2025 or the ROCR Value Based Program ActThis bill establishes a specialized payment program under Medicare for providers and suppliers of radiation oncology services. Specifically, the Centers for Medicare & Medicaid Services (CMS) must establish a program under which radiation therapy providers (i.e., hospital outpatient departments) and suppliers (i.e., physician group practices and freestanding radiation therapy centers) receive payments for each episode of care provided to individuals with specified types of cancer. An episode of care means the period beginning on the day radiation therapy planning is furnished to the individual and ending (1) for individuals with bone or brain metastases, 30 days later; and (2) for individuals with other cancer types, 90 days later.Participation in the program is mandatory for providers and suppliers that participate in Medicare, unless the provider or supplier is part of a state-based Center for Medicare & Medicaid Innovation model or qualifies for a significant hardship exemption. The CMS must set payment rates for the program based on national payment rates with specified adjustments (e.g., geographic adjustments). Providers and suppliers who provide certain transportation services for individuals under their care may receive an additional payment. Providers and suppliers must be accredited in accordance with certain standards, subject to payment reductions.The Government Accountability Office must report on (1) implementation of the program, and (2) underserved areas that are in need of more or newer radiation therapy resources.
Latest Action
Read twice and referred to the Committee on Finance.